Insider Transactions in Q4 2021 at Bio Rad Laboratories, Inc. (BIO)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2021
|
Dara Wright EVP, President, CDG |
SELL
Payment of exercise price or tax liability
|
Direct |
221
-19.86%
|
$162,214
$734.34 P/Share
|
|
Dec 16
2021
|
Dara Wright EVP, President, CDG |
BUY
Exercise of conversion of derivative security
|
Direct |
502
+31.08%
|
-
|
|
Nov 12
2021
|
Annette Tumolo Executive Vice President |
SELL
Open market or private sale
|
Direct |
4,800
-51.1%
|
$3,600,000
$750.05 P/Share
|
|
Nov 12
2021
|
Annette Tumolo Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
4,800
+16.82%
|
$1,118,400
$233.82 P/Share
|
|
Nov 11
2021
|
Annette Tumolo Executive Vice President |
SELL
Open market or private sale
|
Direct |
1,546
-9.2%
|
$1,156,408
$748.97 P/Share
|
|
Nov 11
2021
|
Annette Tumolo Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,546
+8.39%
|
$612,216
$396.99 P/Share
|
|
Nov 09
2021
|
Steven D Schwartz > 10% Shareholder |
BUY
Bona fide gift
|
Indirect |
20
+0.16%
|
-
|
|
Nov 09
2021
|
Steven D Schwartz > 10% Shareholder |
BUY
Bona fide gift
|
Direct |
20
+0.08%
|
-
|
|
Nov 09
2021
|
Alice N Schwartz > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
120
-0.03%
|
-
|
|
Nov 09
2021
|
Alice N Schwartz > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
1,366
-0.08%
|
-
|
|
Nov 09
2021
|
Norman D Schwartz Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
20
+0.16%
|
-
|
|
Nov 09
2021
|
Norman D Schwartz Chairman & CEO |
BUY
Bona fide gift
|
Direct |
20
+0.01%
|
-
|